406 related articles for article (PubMed ID: 8361043)
1. [Blood coagulation-fibrinolysis tests by a biochemical method].
Fukuda C; Iijima K; Nakamura K
Rinsho Byori; 1993 Jul; 41(7):743-9. PubMed ID: 8361043
[TBL] [Abstract][Full Text] [Related]
2. [Use of chromogenic substrates for the diagnosis of blood coagulation and fibrinolytic disorders].
Bokarev IN; Butorov VN; Loginov LE
Ter Arkh; 1981; 53(2):118-24. PubMed ID: 6452714
[No Abstract] [Full Text] [Related]
3. [A new advance in theory of blood coagulation and fibrinolysis and its practical application].
Matsuno K; Araki K
Rinsho Byori; 1991 Feb; 39(2):179-84. PubMed ID: 1904112
[TBL] [Abstract][Full Text] [Related]
4. Synthetic peptide substrate assays in coagulation and fibrinolysis and their application on automates.
Friberger P
Semin Thromb Hemost; 1983 Oct; 9(4):281-300. PubMed ID: 6362011
[No Abstract] [Full Text] [Related]
5. [Standardization of methods for studying fibrinolysis].
García Frade LJ; Obispo TM
Sangre (Barc); 1993 Aug; 38(4):265-6. PubMed ID: 8235938
[No Abstract] [Full Text] [Related]
6. Longitudinal stability of coagulation, fibrinolysis, and inflammation factors in stored plasma samples.
Lewis MR; Callas PW; Jenny NS; Tracy RP
Thromb Haemost; 2001 Dec; 86(6):1495-500. PubMed ID: 11776319
[TBL] [Abstract][Full Text] [Related]
7. Univariate tolerance regions for fibrinogen, antithrombin III, protein C, protein S, plasminogen and alpha 2-antiplasmin in children using the new Automated Coagulation Laboratory (ACL) method.
Nowak-Göttl U; Funk M; Mosch G; Wegerich B; Kornhuber B; Breddin HK
Klin Padiatr; 1994; 206(6):437-9. PubMed ID: 7529848
[TBL] [Abstract][Full Text] [Related]
8. [Behavior of parameters of the blood coagulation and fibrinolytic system in patients with peripheral arteriosclerotic angio-organopathy and in patients after acute phlebothrombosis].
Siegert G; Runge E
Vasa Suppl; 1992; 35():89-91. PubMed ID: 1481076
[No Abstract] [Full Text] [Related]
9. [Etiologic evaluation of deep venous thrombosis: hemostasis tests to perform].
Sie P
Ann Biol Clin (Paris); 1985; 43(6):817-9. PubMed ID: 3841708
[No Abstract] [Full Text] [Related]
10. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
11. Blood coagulation, fibrinolytic, and inhibitory proteins in end-stage renal disease: effect of hemodialysis.
Vaziri ND; Gonzales EC; Wang J; Said S
Am J Kidney Dis; 1994 Jun; 23(6):828-35. PubMed ID: 8203365
[TBL] [Abstract][Full Text] [Related]
12. Newer synthetic peptide substrates in coagulation testing: some practical considerations for automated methods.
Svendsen LG; Fareed J; Walenga JM; Hoppensteadt D
Semin Thromb Hemost; 1983 Oct; 9(4):250-62. PubMed ID: 6658459
[TBL] [Abstract][Full Text] [Related]
13. Circadian variations in coagulation and fibrinolytic factors among four different strains of mice.
Ohkura N; Oishi K; Sakata T; Kadota K; Kasamatsu M; Fukushima N; Kurata A; Tamai Y; Shirai H; Atsumi G; Ishida N; Matsuda J; Horie S
Chronobiol Int; 2007; 24(4):651-69. PubMed ID: 17701678
[TBL] [Abstract][Full Text] [Related]
14. [Blood clotting diagnosis with chromogenic substrates].
Róka L; Rasche H
Internist (Berl); 1980 Apr; 21(4):189-94. PubMed ID: 6998907
[No Abstract] [Full Text] [Related]
15. Hemostatic and fibrinolytic indices in neonatal foals with presumed septicemia.
Barton MH; Morris DD; Norton N; Prasse KW
J Vet Intern Med; 1998; 12(1):26-35. PubMed ID: 9503357
[TBL] [Abstract][Full Text] [Related]
16. Effect of high-dose progestogen on hemostatic properties of blood in patients with endometrial cancer.
Kaibara M; Watanabe T; Ooka F; Liang SG; Aisaka K; Okinaga S
Clin Hemorheol Microcirc; 2001; 24(2):93-9. PubMed ID: 11381184
[TBL] [Abstract][Full Text] [Related]
17. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
[TBL] [Abstract][Full Text] [Related]
18. [Significance of factors of coagulation and fibrinolysis in progression of lung cancer].
Nagayama M; Tachibana A; Hayakawa H; Sato A
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Feb; 31(2):180-5. PubMed ID: 8390588
[TBL] [Abstract][Full Text] [Related]
19. Localization of blood coagulation factors in situ in pancreatic carcinoma.
Wojtukiewicz MZ; Rucinska M; Zacharski LR; Kozlowski L; Zimnoch L; Piotrowski Z; Kudryk BJ; Kisiel W
Thromb Haemost; 2001 Dec; 86(6):1416-20. PubMed ID: 11776308
[TBL] [Abstract][Full Text] [Related]
20. [Rapid determination of protein C activity].
Nicham F; Guichaoua JF; Contant G; Martinoli JL
Ann Biol Clin (Paris); 1988; 46(10):805-9. PubMed ID: 3232870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
